38340-87-3

Upstream product

• 1493-27-2 ortho-nitrofluorobenzene 
• 504-63-2 trimethyleneglycol 
• 88-75-5 2-hydroxynitrobenzene 
• 627-18-9 1-bromo-3-propanol 

Downstream Products

• 920268-18-4 3-(2-aminophenoxy)propan-1-ol 
• 920268-20-8 diethyl 2,2'-(2-(3-bromopropoxy)phenylazanediyl)diethanoate 
• 920268-19-5 diethyl 2,2'-(2-(3-hydroxypropoxy)phenylazanediyl)diethanoate 
• 920268-21-9 diethyl 2,2'-(2-(3-(1,4,7,10-tetraazacyclododec-1-yl)propoxy)phenylazanediyl)diethanoate 
• 920268-22-0 2,2',2''-(10-(3-(2-(bis(carboxymethyl)amino)phenoxy)propyl)-1,4,7,10-tetraazacyclododec-1,4,7-triyl)triethanoic acid 
• 592551-96-7 C₂₅H₂₈FN₃O₃ 
• 592552-29-9 2-(3-((tert-butyldimethylsilyl)oxy)propoxy)aniline 

Relevant academic research and scientific papers

A smart magnetic resonance contrast agent for selective copper sensing

We describe the synthesis and properties of Copper-Gad-1 (CG1), a new type of smart magnetic resonance (MR) sensor for selective detection of copper. CG1 is composed of a gadolinium contrast agent core tethered to copper-selective recognition motif. Cusu

Pyrrolidinyl phenylurea derivatives as novel CCR3 antagonists

Optimization starting with our lead compound 1 (IC50 = 4.9 nM) led to the identification of pyrrolidinyl phenylurea derivatives. Further modification toward improvement of the bioavailability provided (R)-1-(1-((6-fluoronaphthalen-2-yl)methyl)pyrrolidin-3-yl)-3-(2-(2- hydroxyethoxy)phenyl)urea 32 (IC50 = 1.7 nM), a potent and orally active CCR3 antagonist.